{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:53:20Z","timestamp":1791287600381,"version":"4.1.0"},"reference-count":123,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020581","name":"Fondazione AIRC per la ricerca sul cancro ETS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Breast cancer remains one of the leading causes of cancer-related deaths in women. The discovery of a breast tumor microbiota has deeply changed our understanding of the breast tumor microenvironment, identifying microorganisms as active players in tumor progression. Increasing evidence suggests that intratumoral bacteria may influence multiple hallmarks of breast cancer, including chronic inflammation, immune modulation, metabolic reprogramming, epithelial plasticity, metastatic dissemination, and therapeutic response. Distinct microbial communities have been associated with specific breast cancer subtypes and clinical outcomes, and some mechanistic studies have demonstrated that individual bacterial species and their metabolites can directly regulate oncogenic signaling pathways, reshape the tumor immune microenvironment, and alter sensitivity to chemotherapy and immunotherapy. These findings have generated growing interest in exploiting the breast tumor microbiota as a source of novel diagnostic, prognostic, and predictive biomarkers, as well as a therapeutic target for breast cancer treatment. In this review, we summarize current knowledge on the composition and origin of the breast tumor microbiota, discuss the molecular mechanisms through which tumor-associated microorganisms may influence breast cancer initiation and progression, examine their impact on treatment response, and highlight emerging microbiota-based therapeutic strategies. Finally, we discuss the major technical and biological challenges that currently limit clinical translation, including low microbial biomass, contamination, lack of methodological standardization, and patient-related confounding factors, and outline future perspectives for integrating microbial profiling into precision oncology. A deeper understanding of host-microbe interactions within the breast tumor microenvironment may ultimately enable microbiome-informed approaches for personalized prevention, diagnosis, prognostication, and treatment of breast cancer.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1944056","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:16:17Z","timestamp":1791285377000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The intratumoral microbiome in breast cancer: an actionable component of the tumor immune microenvironment"],"prefix":"10.3389","volume":"17","author":[{"given":"Chiara","family":"Cossu","sequence":"first","affiliation":[{"name":"Department of Molecular Biotechnology and Health Sciences, University of Turin","place":["Turin, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Adamo","sequence":"additional","affiliation":[{"name":"Department of Molecular Biotechnology and Health Sciences, University of Turin","place":["Turin, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Di Lorenzo","sequence":"additional","affiliation":[{"name":"Department of Molecular Biotechnology and Health Sciences, University of Turin","place":["Turin, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Conti","sequence":"additional","affiliation":[{"name":"Department of Molecular Biotechnology and Health Sciences, University of Turin","place":["Turin, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41392-023-01693-0","article-title":"Intratumoural microbiota: a new frontier in cancer development and therapy","volume":"9","author":"Cao","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2022.102470","article-title":"The conundrum of breast cancer and microbiome - a comprehensive review of the current evidence","volume":"111","author":"Papakonstantinou","year":"2022","journal-title":"Cancer Treat Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14153811","article-title":"Local breast microbiota: a \"new\" player on the block","volume":"14","author":"Vitorino","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s40168-020-00875-0","article-title":"Microbiome definition re-visited: old concepts and new challenges","volume":"8","author":"Berg","year":"2020","journal-title":"Microbiome"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s11356-021-14593-z","article-title":"Microbiota's role in health and diseases","volume":"28","author":"El-Sayed","year":"2021","journal-title":"Environ Sci pollut Res Int"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1469-0691.2012.03916.x","article-title":"The microbiome as a human organ","volume":"18","author":"Baquero","year":"2012","journal-title":"Clin Microbiol Infection"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1423854112","article-title":"Identifying personal microbiomes using metagenomic codes","volume":"112","author":"Franzosa","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00203-020-01931-x","article-title":"Human microbiome: an academic update on human body site specific surveillance and its possible role","volume":"202","author":"Dekaboruah","year":"2020","journal-title":"Arch Microbiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"goab046","DOI":"10.1093\/gastro\/goab046","article-title":"Microbiome therapeutics: exploring the present scenario and challenges","volume":"10","author":"Yadav","year":"2022","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13058-023-01677-6","article-title":"Exploring breast tissue microbial composition and the association with breast cancer risk factors","volume":"25","author":"German","year":"2023","journal-title":"Breast Cancer Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-023-00594-2","article-title":"Bacteria in cancer initiation, promotion and progression","volume":"23","author":"El Tekle","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc4552","article-title":"The microbiome and human cancer","volume":"371","author":"Sepich-Poore","year":"2021","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.02.027","article-title":"Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer","volume":"185","author":"Fu","year":"2022","journal-title":"Cell"},{"key":"B14","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1136\/gut.47.3.397","article-title":"Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease","volume":"47","author":"Segain","year":"2000","journal-title":"Gut"},{"key":"B15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cmet.2012.12.011","article-title":"Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation","volume":"17","author":"Bennett","year":"2013","journal-title":"Cell Metab"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.119","article-title":"Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis","volume":"15","author":"Jia","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0377-7","article-title":"The microbiome, cancer, and cancer therapy","volume":"25","author":"Helmink","year":"2019","journal-title":"Nat Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.825338","article-title":"Recent advances in understanding the structure and function of the human microbiome","volume":"13","author":"Mousa","year":"2022","journal-title":"Front Microbiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1128\/aem.00242-14","article-title":"Microbiota of human breast tissue","volume":"80","author":"Urbaniak","year":"2014","journal-title":"Appl Environ Microbiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2024.115795","article-title":"The impact of intestinal and mammary microbiomes on breast cancer development: a review on the microbiota and oestrobolome roles in tumour microenvironments","volume":"237","author":"Rozani","year":"2024","journal-title":"Am J Surg"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1128\/aem.01235-16","article-title":"The microbiota of breast tissue and its association with breast cancer","volume":"82","author":"Urbaniak","year":"2016","journal-title":"Appl Environ Microbiol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083744","article-title":"Microbial dysbiosis is associated with human breast cancer","volume":"9","author":"Xuan","year":"2014","journal-title":"PloS One"},{"key":"B23","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.bbcan.2019.04.001","article-title":"The power of small changes: comprehensive analyses of microbial dysbiosis in breast cancer","volume":"1871","author":"Parida","year":"2019","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B24","doi-asserted-by":"publisher","first-page":"586667","DOI":"10.3389\/fcimb.2020.586667","article-title":"The microbiota of the human mammary ecosystem","volume":"10","author":"Fernandez","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2012.10.007","article-title":"Lactococcus lactis subsp. cremoris FC triggers IFN-gamma production from NK and T cells via IL-12 and IL-18","volume":"14","author":"Kosaka","year":"2012","journal-title":"Int Immunopharmacol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70090","article-title":"Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries","volume":"76","author":"Sung","year":"2026","journal-title":"CA: A Cancer J For Clin"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.877384","article-title":"Are cancer stem cells a suitable target for breast cancer immunotherapy","volume":"12","author":"Ruiu","year":"2022","journal-title":"Front Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.610303","article-title":"The crosstalk between tumor cells and the immune microenvironment in breast cancer: implications for immunotherapy","volume":"11","author":"Salemme","year":"2021","journal-title":"Front Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/534969","article-title":"Microenvironment, oncoantigens, and antitumor vaccination: lessons learned from BALB-neuT mice","volume":"2014","author":"Conti","year":"2014","journal-title":"BioMed Res Int"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13020467","article-title":"A systematic review and meta-analysis of 16S rRNA and cancer microbiome atlas datasets to characterize microbiota signatures in normal breast, mastitis, and breast cancer","volume":"13","author":"Rad","year":"2025","journal-title":"Microorganisms"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-020-01338-5","article-title":"Microbiota composition in bilateral healthy breast tissue and breast tumors","volume":"31","author":"Klann","year":"2020","journal-title":"Cancer Causes Control"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.01489-21","article-title":"Composition and functional potential of the human mammary microbiota prior to and following breast tumor diagnosis","volume":"7","author":"Hoskinson","year":"2022","journal-title":"mSystems"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay9189","article-title":"The human tumor microbiome is composed of tumor type-specific intracellular bacteria","volume":"368","author":"Nejman","year":"2020","journal-title":"Science"},{"key":"B34","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13073-021-00874-2","article-title":"Human breast microbiome correlates with prognostic features and immunological signatures in breast cancer","volume":"13","author":"Tzeng","year":"2021","journal-title":"Genome Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/srep30751","article-title":"The microbiome of aseptically collected human breast tissue in benign and malignant disease","volume":"6","author":"Hieken","year":"2016","journal-title":"Sci Rep"},{"key":"B36","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/s41419-021-04092-x","article-title":"Prognostic correlations with the microbiome of breast cancer subtypes","volume":"12","author":"Banerjee","year":"2021","journal-title":"Cell Death Dis"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22169058","article-title":"Uncovering microbial composition in human breast cancer primary tumour tissue using transcriptomic RNA-seq","volume":"22","author":"Hadzega","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2022.02.010","article-title":"The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer","volume":"34","author":"Wang","year":"2022","journal-title":"Cell Metab"},{"key":"B39","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41522-025-00816-5","article-title":"Unravelling novel microbial players in the breast tissue of TNBC patients: a meta-analytic perspective","volume":"11","author":"Rashwan","year":"2025","journal-title":"NPJ Biofilms Microbiomes"},{"key":"B40","doi-asserted-by":"publisher","first-page":"11940","DOI":"10.1038\/s41598-019-48348-1","article-title":"Distinct microbial communities that differ by race, stage, or breast-tumor subtype in breast tissues of non-Hispanic Black and non-Hispanic White women","volume":"9","author":"Smith","year":"2019","journal-title":"Sci Rep"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqac177","article-title":"Gut and breast microbiota as endocrine regulators of hormone receptor-positive breast cancer risk and therapy response","volume":"164","author":"Arnone","year":"2022","journal-title":"Endocrinology"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00318","article-title":"Study of microbiomes in aseptically collected samples of human breast tissue using needle biopsy and the potential role of in situ tissue microbiomes for promoting malignancy","volume":"8","author":"Meng","year":"2018","journal-title":"Front Oncol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137091","article-title":"Exploring the relationship between microRNAs, intratumoral microbiota, and breast cancer progression in patients with and without metastasis","volume":"25","author":"Laborda-Illanes","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.32604\/or.2026.076380","article-title":"Comparative analysis of tumor microbiota identifies a metastatic-specific bacterial signature, highlighting Streptococcus spp. as the predominant hub across cancers","volume":"34","author":"Todorovic","year":"2026","journal-title":"Oncol Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03595-24","article-title":"Identification of intratumoral bacteria that enhance breast tumor metastasis","volume":"16","author":"Gerbec","year":"2025","journal-title":"mBio"},{"key":"B46","doi-asserted-by":"publisher","first-page":"16893","DOI":"10.1038\/s41598-018-35329-z","article-title":"Characterization of human breast tissue microbiota from core needle biopsies through the analysis of multi hypervariable 16S-rRNA gene regions","volume":"8","author":"Costantini","year":"2018","journal-title":"Sci Rep"},{"key":"B47","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1038\/s41467-020-16967-2","article-title":"Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression","volume":"11","author":"Parhi","year":"2020","journal-title":"Nat Commun"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2016.07.006","article-title":"Fap2 mediates Fusobacterium nucleatum colorectal adenocarcinoma enrichment by binding to tumor-expressed Gal-GalNAc","volume":"20","author":"Abed","year":"2016","journal-title":"Cell Host Microbe"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2021.03.004","article-title":"Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver","volume":"39","author":"Bertocchi","year":"2021","journal-title":"Cancer Cell"},{"key":"B50","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12885-022-09274-0","article-title":"Mammary tumors alter the fecal bacteriome and permit enteric bacterial translocation","volume":"22","author":"Loman","year":"2022","journal-title":"BMC Cancer"},{"key":"B51","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41392-022-01304-4","article-title":"Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy","volume":"8","author":"Yang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70273","article-title":"Integrated spatial multi-omics profiling of Fusobacterium nucleatum in breast cancer unveils its role in tumour microenvironment modulation and cancer progression","volume":"15","author":"Zhao","year":"2025","journal-title":"Clin Transl Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202400694","article-title":"Whole-tumor clearing and imaging of intratumor microbiota in three dimensions with miCDaL strategy","volume":"11","author":"Wang","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05435-0","article-title":"Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer","volume":"611","author":"Galeano Nino","year":"2022","journal-title":"Nature"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1140995","article-title":"Integrating bulk and single-cell RNA sequencing data reveals the relationship between intratumor microbiome signature and host metabolic heterogeneity in breast cancer","volume":"14","author":"Chen","year":"2023","journal-title":"Front Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188873","article-title":"A comprehensive analysis of breast cancer microbiota and host gene expression","volume":"12","author":"Thompson","year":"2017","journal-title":"PloS One"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1126\/science.1127059","article-title":"Escherichia coli induces DNA double-strand breaks in eukaryotic cells","volume":"313","author":"Nougayrede","year":"2006","journal-title":"Science"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.34751","article-title":"Helicobacter pylori impairs DNA mismatch repair in gastric epithelial cells","volume":"123","author":"Kim","year":"2002","journal-title":"Gastroenterology"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005517","article-title":"Attaching and effacing Escherichia coli downregulate DNA mismatch repair protein in vitro and are associated with colorectal adenocarcinomas in humans","volume":"4","author":"Maddocks","year":"2009","journal-title":"PloS One"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-017-2171-6","article-title":"Intratumoral Fusobacterium nucleatum abundance correlates with macrophage infiltration and CDKN2A methylation in microsatellite-unstable colorectal carcinoma","volume":"471","author":"Park","year":"2017","journal-title":"Virchows Arch"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12975","article-title":"Lipopolysaccharide from the commensal microbiota of the breast enhances cancer growth: role of S100A7 and TLR4","volume":"16","author":"Wilkie","year":"2022","journal-title":"Mol Oncol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1096\/fj.13-230201","article-title":"The noninflammatory role of high mobility group box 1\/Toll-like receptor 2 axis in the self-renewal of mammary cancer stem cells","volume":"27","author":"Conti","year":"2013","journal-title":"FASEB J"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2022.2086752","article-title":"Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy","volume":"11","author":"Di Lorenzo","year":"2022","journal-title":"Oncoimmunology"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25010456","article-title":"The role of the Toll-like receptor 2 and the cGAS-STING pathways in breast cancer: Friends or foes","volume":"25","author":"Cossu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249418","article-title":"Toll-like receptor 2 at the crossroad between cancer cells, the immune system, and the microbiota","volume":"21","author":"Di Lorenzo","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-025-02635-9","article-title":"A pro-carcinogenic oral microbe internalized by breast cancer cells promotes mammary tumorigenesis","volume":"24","author":"Parida","year":"2026","journal-title":"Cell Commun Signal"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2038852","DOI":"10.1080\/19490976.2022.2038852","article-title":"Fusobacterium nucleatum promotes colorectal cancer cells adhesion to endothelial cells and facilitates extravasation and metastasis by inducing ALPK1\/NF-kappaB\/ICAM1 axis","volume":"14","author":"Zhang","year":"2022","journal-title":"Gut Microbes"},{"key":"B68","doi-asserted-by":"publisher","first-page":"415","DOI":"10.21037\/tcr-2025-1-2727","article-title":"Fusobacterium nucleatum promotes colorectal cancer metastasis by modulating the NF-kappaB-MMP-2\/MMP-9 signaling pathway","volume":"15","author":"Peng","year":"2026","journal-title":"Transl Cancer Res"},{"key":"B69","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41522-023-00446-9","article-title":"Intracellular bacteria in cancer-prospects and debates","volume":"9","author":"Schorr","year":"2023","journal-title":"NPJ Biofilms Microbiomes"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djw029","article-title":"The intestinal microbiome and estrogen receptor-positive female breast cancer","volume":"108","author":"Kwa","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/srep28061","article-title":"Characterization of the microbiome of nipple aspirate fluid of breast cancer survivors","volume":"6","author":"Chan","year":"2016","journal-title":"Sci Rep"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-20-0537","article-title":"A procarcinogenic colon microbe promotes breast tumorigenesis and metastatic progression and concomitantly activates Notch and beta-catenin axes","volume":"11","author":"Parida","year":"2021","journal-title":"Cancer Discov"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23169490","article-title":"Gut metabolites and breast cancer: The continuum of dysbiosis, breast cancer risk, and potential breast cancer therapy","volume":"23","author":"Jaye","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3390\/applmicrobiol5040134","article-title":"From dysbiosis to diagnosis: The role of gut microbiota in breast cancer etiology and management","volume":"5","author":"Mishra","year":"2025","journal-title":"Appl Microbiol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s42255-025-01287-w","article-title":"The gut microbiome and cancer: from tumorigenesis to therapy","volume":"7","author":"Nobels","year":"2025","journal-title":"Nat Metab"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.01.010","article-title":"Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack","volume":"42","author":"Gur","year":"2015","journal-title":"Immunity"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-17-1134","article-title":"The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression","volume":"8","author":"Pushalkar","year":"2018","journal-title":"Cancer Discov"},{"key":"B78","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","article-title":"Tumor microbiome diversity and composition influence pancreatic cancer outcomes","volume":"178","author":"Riquelme","year":"2019","journal-title":"Cell"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.04104-23","article-title":"Multi-omics analysis elucidates the relationship between intratumor microbiome and host immune heterogeneity in breast cancer","volume":"12","author":"Li","year":"2024","journal-title":"Microbiol Spectr"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.216041","article-title":"Reduction of Staphylococcus epidermidis in the mammary tumor microbiota induces antitumor immunity and decreases breast cancer aggressiveness","volume":"555","author":"Bernardo","year":"2023","journal-title":"Cancer Lett"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-026-48719-5","article-title":"Breast tumor microbiome regulates anti-tumor immunity and T cell-associated metabolites","volume":"16","author":"Liu","year":"2026","journal-title":"Sci Rep"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2025.12.044","article-title":"Divergent tumor immunity determined by bacteria-cancer cell engagement","volume":"189","author":"Yao","year":"2026","journal-title":"Cell"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-021-00784-1","article-title":"Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment","volume":"28","author":"Terrisse","year":"2021","journal-title":"Cell Death Differ"},{"key":"B85","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41522-025-00825-4","article-title":"Optimizing breast cancer chemotherapy by harnessing gut microbiota with insights from artificial intelligence","volume":"11","author":"Zhou","year":"2025","journal-title":"NPJ Biofilms Microbiomes"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14194849","article-title":"Intestinal microbiota influence doxorubicin responsiveness in triple-negative breast cancer","volume":"14","author":"Bawaneh","year":"2022","journal-title":"Cancers"},{"key":"B87","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1021\/acsinfecdis.7b00166","article-title":"Transformation of the anticancer drug doxorubicin in the human gut microbiome","volume":"4","author":"Yan","year":"2018","journal-title":"ACS Infect Dis"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00068-21","article-title":"Biotransformation of doxorubicin promotes resilience in simplified intestinal microbial communities","volume":"6","author":"Blaustein","year":"2021","journal-title":"mSphere"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01679-24","article-title":"Variation in human gut microbiota impacts tamoxifen pharmacokinetics","volume":"16","author":"Alam","year":"2025","journal-title":"mBio"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.mcr-19-0451","article-title":"Neoadjuvant chemotherapy shifts breast tumor microbiota populations to regulate drug responsiveness and the development of metastasis","volume":"18","author":"Chiba","year":"2020","journal-title":"Mol Cancer Res MCR"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-026-08187-x","article-title":"Intratumoral microbiota exhibiting varied responses to neoadjuvant chemotherapy in triple-negative breast cancer revealed by 2bRAD-M","volume":"24","author":"Zhang","year":"2026","journal-title":"J Transl Med"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-026-01004-0","article-title":"Impact of neoadjuvant chemotherapy on local breast microbiota and macrophages in ER-positive breast cancer with links to treatment response","author":"Dieleman","year":"2026","journal-title":"NPJ Breast Cancer"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1093\/procel\/pwae005","article-title":"Microbiota enterotoxigenic Bacteroides fragilis-secreted BFT-1 promotes breast cancer cell stemness and chemoresistance through its functional receptor NOD1","volume":"15","author":"Ma","year":"2024","journal-title":"Protein Cell"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.14356","article-title":"Immunogenic cell death in cancer therapy: Present and emerging inducers","volume":"23","author":"Zhou","year":"2019","journal-title":"J Cell Mol Med"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2023.330","article-title":"Tumor microenvironment can predict chemotherapy response of patients with triple-negative breast cancer receiving neoadjuvant chemotherapy","volume":"56","author":"Kim","year":"2024","journal-title":"Cancer Res Treat"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010365","article-title":"Intratumoral microbiota predicts the response to neoadjuvant chemoimmunotherapy in triple-negative breast cancer","volume":"13","author":"Chen","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2024.111168","article-title":"Fusobacterium nucleatum promotes PD-L1 expression in cancer cells to evade CD8(+) T cell killing in breast cancer","volume":"85","author":"Guo","year":"2024","journal-title":"Hum Immunol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.5812\/jjm.8(4)2015.17354","article-title":"Th1 cytokine production induced by Lactobacillus acidophilus in BALB\/c mice bearing transplanted breast tumor","volume":"8","author":"Imani Fooladi","year":"2015","journal-title":"Jundishapur J Microbiol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1186\/bcr1032","article-title":"Effects of milk fermented by Lactobacillus helveticus R389 on a murine breast cancer model","volume":"7","author":"de Moreno de LeBlanc","year":"2005","journal-title":"Breast Cancer Res"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11072030","article-title":"Staphylococcus aureus-derived extracellular vesicles enhance the efficacy of endocrine therapy in breast cancer cells","volume":"11","author":"An","year":"2022","journal-title":"J Clin Med"},{"key":"B101","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejca.2021.11.006","article-title":"Probiotic supplement attenuates chemotherapy-related cognitive impairment in patients with breast cancer: a randomised, double-blind, and placebo-controlled trial","volume":"161","author":"Juan","year":"2022","journal-title":"Eur J Cancer"},{"key":"B102","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.celrep.2018.08.078","article-title":"Consumption of Mediterranean versus Western diet leads to distinct mammary gland microbiome populations","volume":"25","author":"Shively","year":"2018","journal-title":"Cell Rep"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.capr-24-0055","article-title":"Diet modulates the gut microbiome, metabolism, and mammary gland inflammation to influence breast cancer risk","volume":"17","author":"Arnone","year":"2024","journal-title":"Cancer Prev Res (Phila)"},{"key":"B104","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1038\/s41467-023-37636-0","article-title":"Antimicrobial exposure is associated with decreased survival in triple-negative breast cancer","volume":"14","author":"Ransohoff","year":"2023","journal-title":"Nat Commun"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.3c12687","article-title":"Biomimetic nanovehicle-enabled targeted depletion of intratumoral Fusobacterium nucleatum synergizes with PD-L1 blockade against breast cancer","volume":"18","author":"Geng","year":"2024","journal-title":"ACS Nano"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.6c03081","article-title":"A target-and-activate magnetic resonance imaging strategy for precision imaging of intratumoral bacteria and screening antibiotics to suppress breast cancer metastasis","volume":"148","author":"Wu","year":"2026","journal-title":"J Am Chem Soc"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-018-0070-z","article-title":"Tumour-targeting bacteria engineered to fight cancer","volume":"18","author":"Zhou","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1038\/nature18930","article-title":"Synchronized cycles of bacterial lysis for in vivo delivery","volume":"536","author":"Din","year":"2016","journal-title":"Nature"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0498-z","article-title":"Programmable bacteria induce durable tumor regression and systemic antitumor immunity","volume":"25","author":"Chowdhury","year":"2019","journal-title":"Nat Med"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax0876","article-title":"Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies","volume":"12","author":"Gurbatri","year":"2020","journal-title":"Sci Transl Med"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3003657","article-title":"Engineered romidepsin biosynthetic pathways in Escherichia coli Nissle 1917 improve the efficacy of bacteria-mediated cancer therapy","volume":"24","author":"Ma","year":"2026","journal-title":"PloS Biol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.chempr.2024.01.030","article-title":"Fusobacterium nucleatum-mimicking nanovehicles to overcome chemoresistance for breast cancer treatment by eliminating tumor-colonizing bacteria","volume":"10","author":"Chen","year":"2024","journal-title":"Chem"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.3c09472","article-title":"Transforming intratumor bacteria into immunopotentiators to reverse cold tumors for enhanced immuno-chemodynamic therapy of triple-negative breast cancer","volume":"145","author":"Liu","year":"2023","journal-title":"J Am Chem Soc"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.486","article-title":"Direct incorporation of the NKT-cell activator alpha-galactosylceramide into a recombinant Listeria monocytogenes improves breast cancer vaccine efficacy","volume":"111","author":"Singh","year":"2014","journal-title":"Br J Cancer"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1685862","DOI":"10.3389\/fcimb.2025.1685862","article-title":"Emerging technologies and current challenges in intratumoral microbiota research","volume":"15","author":"Wang","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12943-025-02403-w","article-title":"The tumor microbiome in cancer progression: mechanisms and therapeutic potential","volume":"24","author":"Zhang","year":"2025","journal-title":"Mol Cancer"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202200470","article-title":"Microbiota in tumors: From understanding to application","volume":"9","author":"Xie","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-025-02035-2","article-title":"Guidelines for preventing and reporting contamination in low-biomass microbiome studies","volume":"10","author":"Fierer","year":"2025","journal-title":"Nat Microbiol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"18535","DOI":"10.1038\/s41598-021-98089-3","article-title":"Biopsy bacterial signature can predict patient tissue malignancy","volume":"11","author":"Hogan","year":"2021","journal-title":"Sci Rep"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.62347\/zjcf2843","article-title":"The microbiota in breast cancer: dysbiosis, microbial metabolites, and therapeutic implications","volume":"15","author":"Liu","year":"2025","journal-title":"Am J Cancer Res"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-018-0029-9","article-title":"Best practices for analysing microbiomes","volume":"16","author":"Knight","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-014-0087-z","article-title":"Reagent and laboratory contamination can critically impact sequence-based microbiome analyses","volume":"12","author":"Salter","year":"2014","journal-title":"BMC Biol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.105035","article-title":"Intratumoral microbiome in breast cancer: A hidden player in tumor development, progression and treatment response","volume":"217","author":"Canzian","year":"2026","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1944056\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:16:18Z","timestamp":1791285378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1944056\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":123,"alternative-id":["10.3389\/fimmu.2026.1944056"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1944056","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"article-number":"1944056"}}